Trends of diabetes in Beijing, China

Author:

Ma Aijuan12,Lyu Jun134,Dong Zhong2,Nie Li2,Xie Chen2,Jiang Bo2,Han Xueyu2,Dong Jing2,Zhao Yue2,Li Liming134

Affiliation:

1. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China

2. Institute of Chronic Non-Communicable Disease Control and Prevention, Beijing Center for Disease Prevention and Control, Beijing 100013, China

3. Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing 100191, China

4. Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing 100191, China

Abstract

Abstract Background: The global rise in diabetes prevalence is a pressing concern. Despite initiatives like “The Healthy Beijing Action 2020–2030” advocating for increased awareness, treatment, and control, the specific situation in Beijing remains unexplored. This study aimed to analyze the trends in diabetes prevalence, awareness, treatment, and control among Beijing adults. Methods: Through a stratified multistage probability cluster sampling method, a series of representative cross-sectional surveys were conducted in Beijing from 2005 to 2022, targeting adults aged 18–79 years. A face-to-face questionnaire, along with body measurements and laboratory tests, were administered to 111,943 participants. Data from all survey were age- and/or gender-standardized based on the 2020 Beijing census population. Annual percentage rate change (APC) or average annual percentage rate change (AAPC) was calculated to determine prevalence trends over time. Complex sampling logistic regression models were employed to explore the relationship between various characteristics and diabetes. Results: From 2005 to 2022, the total prevalence of diabetes among Beijing adults aged 18–79 years increased from 9.6% (95% CI: 8.8–10.4%) to 13.9% (95% CI: 13.1–14.7%), with an APC/AAPC of 2.1% (95% CI: 1.1–3.2%, P <0.05). Significant increases were observed among adults aged 18–39 years and rural residents. Undiagnosed diabetes rose from 3.5% (95% CI: 3.2–4.0%) to 7.2% (95% CI: 6.6–7.9%) with an APC/AAPC of 4.1% (95% CI: 0.5–7.3%, P <0.05). However, diabetes awareness and treatment rates showed annual declines of 1.4% (95% CI: −3.0% to −0.2%, P <0.05) and 1.3% (95% CI: −2.6% to −0.2%, P <0.05), respectively. The diabetes control rate decreased from 21.5% to 19.1%, although not statistically significant (APC/AAPC = −1.5%, 95% CI: −5.6% to 1.9%). Overweight and obesity were identified as risk factors for diabetes, with ORs of 1.65 (95% CI: 1.38–1.98) and 2.48 (95% CI: 2.07–2.99), respectively. Conclusions: The prevalence of diabetes in Beijing has significantly increased between 2005 and 2022, particularly among young adults and rural residents. Meanwhile, there has been a concerning decrease in diabetes awareness and treatment rates, while control rates have remained stagnant. Regular blood glucose testing, especially among adults aged 18–59 years, should be warranted. Furthermore, being male, elderly, overweight, or obese was associated with higher diabetes risk, suggesting the needs for targeted management strategies.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3